Omega Therapeutics (OMGA) Projected to Post Quarterly Earnings on Thursday

Omega Therapeutics (NASDAQ:OMGA) is expected to release its earnings data before the market opens on Thursday, March 27th. Analysts expect Omega Therapeutics to post earnings of ($0.28) per share for the quarter.

Omega Therapeutics Price Performance

OMGA stock opened at $0.13 on Tuesday. The stock’s 50 day moving average is $0.26 and its two-hundred day moving average is $0.76. Omega Therapeutics has a 52-week low of $0.10 and a 52-week high of $3.77. The company has a market capitalization of $6.92 million, a PE ratio of -0.09 and a beta of 1.65. The company has a quick ratio of 1.61, a current ratio of 1.61 and a debt-to-equity ratio of 1.00.

Omega Therapeutics Company Profile

Omega Therapeutics, Inc operates as a clinical-stage biotechnology company. The company's OMEGA platform enables control of fundamental epigenetic processes to correct the root cause of disease by restoring aberrant gene expression to a range without altering native nucleic acid sequences. It also develops OTX-2002 for hepatocellular carcinoma; OTX-2101 for non-small cell lung cancer; omega epigenomic controllers (OEC) for inflammatory lung diseases, such as neutrophilic asthma, acute respiratory distress syndrome, dermatological, oncology, and rheumatological indications; OEC candidates for idiopathic pulmonary fibrosis; liver regeneration medicines; and OEC candidates for patients with diabetes and other conditions to treat corneal epithelial injury.